Lack of intent evidence dooms drugmaker fine

Ruling that Switzerland’s antitrust authority failed to provide sufficient evidence of anticompetitive intent, a Swiss court has found that Pfizer, Eli Lilly, and Bayer are no longer guilty of illegally setting minimum prices for their erectile dysfunction medication.